Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 May;55(5):331–332. doi: 10.1136/ard.55.5.331-b

Effect of isradipine on endothelin-1 plasma concentrations in patients with Raynaud's phenomenon.

L La Civita, D Giuggioli, M G Del Chicca, G Longombardo, G Pasero, C Ferri
PMCID: PMC1010174  PMID: 8660111

Full text

PDF
331

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biondi M. L., Marasini B., Bassani C., Agastoni A. Increased plasma endothelin levels in patients with Raynaud's phenomenon. N Engl J Med. 1991 Apr 18;324(16):1139–1140. [PubMed] [Google Scholar]
  2. Cleophas T. J., Niemeyer M. G. Raynaud's syndrome, an enigma after 130 years. Angiology. 1993 Mar;44(3):196–209. doi: 10.1177/000331979304400305. [DOI] [PubMed] [Google Scholar]
  3. Ferri C., Bernini L., Cecchetti R., Latorraca A., Marotta G., Pasero G., Neri R., Bombardieri S. Cutaneous and serologic subsets of systemic sclerosis. J Rheumatol. 1991 Dec;18(12):1826–1832. [PubMed] [Google Scholar]
  4. Ferri C., La Civita L., Zignego A. L., Longombardo G., Del Chicca M. G., Pedrinelli R., Greco F., Pasero G., Bombardieri S. Plasma levels of endothelin-1 in mixed cryoglobulinaemia patients. Br J Rheumatol. 1994 Jul;33(7):689–690. doi: 10.1093/rheumatology/33.7.689. [DOI] [PubMed] [Google Scholar]
  5. Kallenberg C. G., Pastoor G. W., Wouda A. A., The T. H. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis. 1982 Aug;41(4):382–387. doi: 10.1136/ard.41.4.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Levin E. R. Endothelins. N Engl J Med. 1995 Aug 10;333(6):356–363. doi: 10.1056/NEJM199508103330607. [DOI] [PubMed] [Google Scholar]
  7. Maricq H. R. Wide-field capillary microscopy. Arthritis Rheum. 1981 Sep;24(9):1159–1165. doi: 10.1002/art.1780240907. [DOI] [PubMed] [Google Scholar]
  8. Wollersheim H., van Zwieten P. A. Treatment of Raynaud's phenomenon. Eur Heart J. 1993 Feb;14(2):147–149. doi: 10.1093/eurheartj/14.2.147. [DOI] [PubMed] [Google Scholar]
  9. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES